Catalyst Wire Dossier Catalyst Wire Dossier

Tyvaso (treprostinil inhalation)

Treprostinil · United Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tyvaso (treprostinil inhalation), covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) [Phase 3]

See pricing